SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-324862
Filing Date
2018-11-13
Accepted
2018-11-13 07:51:58
Documents
46
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d619105d10q.htm 10-Q 248000
2 EXHIBIT 31.1 d619105dex311.htm EX-31.1 11027
3 EXHIBIT 31.2 d619105dex312.htm EX-31.2 11786
4 EXHIBIT 32.1 d619105dex321.htm EX-32.1 5502
5 EXHIBIT 32.2 d619105dex322.htm EX-32.2 6249
  Complete submission text file 0001193125-18-324862.txt   1942677

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20180930.xml EX-101.INS 214675
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20180930.xsd EX-101.SCH 29314
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20180930_cal.xml EX-101.CAL 29103
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20180930_def.xml EX-101.DEF 179455
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20180930_lab.xml EX-101.LAB 251360
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20180930_pre.xml EX-101.PRE 209268
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 181175179
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1